Where AI is (and isn't) changing commercial work
About this Event
MATTER, with the support of EVERSANA INTOUCH, is producing AI in Commercial Pharma, a four-part series exploring how commercial pharma teams are prioritizing AI use cases, evaluating solutions and moving from pilots to production.
The second event in the series will feature a panel discussion with pharma brand, commercial, market access and analytics leaders to discuss their approaches to AI: where they are finding value, how they are evaluating solutions, what they are building versus buying and what they see as the most significant barriers to adoption.
Speakers include:
- Faruk Capan, founder, EVERSANA INTOUCH and chief innovation officer, EVERSANA
- Thomas Gibbs, EVP and president, Lundbeck U.S.
- Jared Josleyn, senior vice president, global head of digital health and emerging disruptive growth exploration, Sanofi
Agenda:
3:00pm CT | Doors open
3:30pm CT | Panel discussion begins
4:30pm CT | Networking reception
5:00pm CT | Event concludes
Part of the AI in Commercial Pharma event series
Explore all four events and choose the one that’s right for you.
About Faruk Capan
Faruk Capan is the founder of EVERSANA INTOUCH and chief innovation officer of EVERSANA. A lifelong entrepreneur, Faruk founded Intouch in 1999 after creating MSWatch.com, the first and largest online community for people living with multiple sclerosis. Today, he is a leading voice on the intersection of artificial intelligence, commercialization and healthcare innovation, shaping the future of life sciences through strategic platforms and partnerships with organizations including Google Cloud, AWS and Adobe. Under his leadership, EVERSANA has developed industry-leading AI-powered commercialization solutions designed to transform how therapies reach patients. He leads global teams focused on accelerating innovation while maintaining a people-first culture.
About Thomas Gibbs
Tom Gibbs joined Lundbeck in February 2023 with more than 25 years of diverse corporate, general management and commercial leadership experience, including roles in executive management, marketing, sales, commercial operations, customer insights and analytics and finance at small, mid-size and large pharmaceutical companies.
Prior to Lundbeck, Tom served as chief executive officer and global business leader of Vectura Inc. Prior to his role at Vectura Inc., Tom held several chief commercial officer roles, developing commercial strategy and overseeing execution for U.S., Canadian and European markets at pharmaceutical companies with strong central nervous system (CNS) franchises, including a role as chief commercial officer at Sunovion. He has also served as head of general medicines in the U.S. for Takeda.
Tom holds a BS in economics with a dual concentration in finance and marketing and an MBA from the Wharton School of the University of Pennsylvania.
About Jared Josleyn
Jared Josleyn is Sanofi's senior vice president and global head of E.D.G.E. (Emerging Disruptive Growth Exploration), where he leads Project Saturn — a federated health data infrastructure platform that activates the full support network around people through relationship-powered care coordination while enabling privacy-preserving AI.
At Sanofi, he is responsible for developing and delivering breakthrough technologies and care solutions that improve the lives of people and their loved ones through both internal creation and external partnership, with current focus on federated machine learning for early disease detection, AI-enabled screening and building the infrastructure for a new health economy where people and communities benefit from — rather than lose control of — their health data.
Prior to joining Sanofi, Jared served as vice president of innovation and chief product and experience officer for Walgreens Boots Alliance (WBA), where he founded and launched Walgreens Health. Before joining WBA, he held leadership positions at Alphabet across Google Health, Google Life Sciences and Verily.
About MATTER
At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes more than 1,000 current and alumni startups from around the world, working together with hospitals, health systems, universities and industry-leading companies to build the future of healthcare. Together we are accelerating innovation, advancing care and improving lives.
About EVERSANA INTOUCH
EVERSANA INTOUCH helps life sciences organizations accelerate commercial success by unifying strategy, creative, execution, data with AI and human expertise to deliver measurable business impact at enterprise scale.
Where is it happening?
Event Location & Nearby Stays:
USD 0.00
